DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

Rexahn Pharmaceuticals (NYSEMKT: RNN)

0.71 -0.01 (-0.70%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RNN $0.71 -0.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.71
Previous Close $0.72
Daily Range $0.71 - $0.72
52-Week Range $0.65 - $1.05
Market Cap $127.3M
P/E Ratio -6.50
Dividend (Yield) $0.00 (0.0%)
Volume 275,949
Average Daily Volume 587,249
Current FY EPS -$0.11

Sector

Healthcare

Industry

Drug Makers

Rexahn Pharmaceuticals (RNN) Description

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Website: http://www.rexahn.com/

News & Commentary

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

Rexahn Pharmaceuticals to Present Data on RX-3117 & Supinoxin at the 2015 American Association for C

Rexahn Pharmaceuticals to Present Data on RX-3117 & Supinoxin at the 2015 American Association for Cancer Research Annual Meeting

Rexahn Pharmaceuticals: One Biotech To Buy For A Catalyst-Filled 2015

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Fl

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Flexibility

Onxeo: An Upcoming Mid-Sized Pharma With Ambitions

Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off

Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 12.5% - Tale of the Tape

Can The Uptrend Continue for Rexahn Pharmaceuticals (RNN)? - Tale of the Tape

Update: Rexahn Likens Partnership With Demonstrated Potential Of RX-3117

Why Rexahn Pharmaceuticals (RNN) Could Be Positioned for a Surge? - Tale of the Tape

Rexahn Pharmaceuticals (RNN): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

See More RNN News...

RNN's Top Competitors

RNN $0.71 (-0.70%)
Current stock: RNN
AMGN $162.11 (1.09%)
Current stock: AMGN
GILD $105.66 (0.62%)
Current stock: GILD
BIIB $386.22 (0.00%)
Current stock: BIIB